Document is current
Any future updates will be listed below
-
Authors
Mohan, Vikram https://orcid.org/0000-0002-9067-2817
Rathinam, Chandrasekar
Yates, Derick
Voicu, Andra
Malotra, Charanjet
Riley, Isabelle
Aiyegbusi, Olalekan Lee
Nagakumar, Prasad
-
Funding
Funding for this research was provided by:
National Institute for Health and Care Research (NIHR304372)
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 19 September 2025
First Online: 10 October 2025
Declarations
:
: OLA receives funding from the NIHR Birmingham Biomedical Research Centre (BRC), NIHR Applied Research Collaboration (ARC), West Midlands, NIHR Blood and Transplant Research Unit (BTRU) in Precision Transplant and Cellular Therapeutics at the University of Birmingham and University Hospitals Birmingham NHS Foundation, LifeArc, Innovate UK (part of UK Research and Innovation), The Health Foundation, Gilead Sciences Ltd, Merck, Anthony Nolan, GSK, and Sarcoma UK. He declares personal fees from Gilead Sciences, Merck, Innovate UK, and GSK outside the submitted work. Other authors declare no conflicts of interest.
: Not applicable.
: Not applicable.
: Not applicable.
